Medical Condition

cirrhosis

Total Trials

13

Recruiting Now

13

Trial Phases

Phase 3, Phase 2, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for cirrhosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cirrhosis Clinical Trials

How many clinical trials are currently recruiting for cirrhosis?

ClinicalMetric currently tracks 13 actively recruiting clinical trials for cirrhosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for cirrhosis?

cirrhosis research spans Phase 1 (1 trial), Phase 2 (4 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a cirrhosis clinical trial?

Eligibility criteria for cirrhosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 2 trials

First Affiliated Hospital of Wenzhou Medical University 1 trial

Hospices Civils de Lyon 1 trial

University of California, San Francisco 1 trial

Stacy Johnson 1 trial

Recruiting Clinical Trials

NCT06316869

Recruiting

Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch Viscoelastography

First Affiliated Hospital of W...

View Trial →

NCT03905746

Recruiting

Study of microRNAs in a Decompensated Cirrhosis

Hospices Civils de Lyon

View Trial →

NCT07029243

Recruiting

Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis

University of California, San ...

View Trial →

NCT06941415 Phase 3

Recruiting

Bumetanide vs. Furosemide in Cirrhosis

A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

University Hospital, Lille

View Trial →

NCT06812390 Phase 2

Recruiting

Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites

Anahita Rabiee MD MHS

View Trial →

NCT07172035

Recruiting

The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis

Union Hospital, Tongji Medical...

View Trial →

NCT06007846 Phase 2, Phase 3

Recruiting

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

Inova Health Care Services

View Trial →

NCT07042919 Phase 1, Phase 2

Recruiting

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Devalingam Mahalingam

View Trial →

NCT06937307 Phase 2

Recruiting

Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury

EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG

Fundacio Privada Mon Clinic Ba...

View Trial →

NCT07461532

Recruiting

Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD

Northern Jiangsu People's Hosp...

View Trial →

NCT07281846

Recruiting

TIPS With or Without BCAA

Union Hospital, Tongji Medical...

View Trial →

Related Conditions

portal hypertension (2) sarcopenia (2) acute decompensation (1) frailty (1) surgery (1) obesity (1) nash nonalcoholic steatohepatitis (1) ascites hepatic (1) decompensation (1) transjugular intrahepatic portosystemic shunt tips (1) survival analysis (1) hepatocellular carcinoma (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology